Exclusives

Avita achieves a milestone with the first US burn center to treat a patient using its RECELL GO System. The product is a next-generation autologous cell harvesting device that uses a patient’s own skin to treat thermal burn wounds and...

Mölnlycke is partnering with Yuncture, an entrepreneurial incubator, to identify and collaborate with start-ups through the “Yuncture incubator program.” The partnership will run from Sept 2024 to Jan 2025.

Case series with OptiView Transparent Gel Dressing reported a 74.9% average reduction in deep-tissue pressure injury wound area. The average time to wound closure that completely healed after dressing application was 18.3 days. SAWC Spring...

A 60-patient RCT found that Altrazeal transforming powder dressing (TPD) was associated with higher healing rates, shorter duration of healing, less pain, and decreased dressing changes compared to current SOC in the treatnebt of CVUs. SAWC...

CMS released 4 new A codes at the First CMS Biannual 2024 HCPCS Public Meeting including xenoPatch (manufactured by DSM) for Extremity Care, MatriDerm (manufactured by MedSkin) for Access Medical, MicroMatrix Flex for Integra, and MiroTract...

In May 2024, BioMonde was awarded a share of ~$1.1MM (£900k) of funding support from the Welsh government-backed SMART FIS program. The funding will be used to develop products from larval secretions.

Avita Medical announced the FDA has approved its premarket approval for the RECELL GO System, a next-generation autologous cell harvesting device for treating thermal burn wounds and full-thickness skin defects. The company plans to launch in...

An interim analysis of a 50-patient RCT demonstrated a 44% reduction in time for achieving DFU healing when using a novel polylactic acid (PLA) matrix vs a collagen dressing. A significant increase in blood flow and granulation tissue was...